Effects of dopamine agonists and antagonists on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test

Psychopharmacology

Volumn 135, Issue 2, 1998, Pages 182-193

  Sams Dodd, Frank ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

( ) Sulpiride; Antipsychotic; L 745,870; Negative symptom; Positive symptom; Quinpirole; Rat; SCH 23390; Schizophrenia; SK and F 81297; SK and F 83393; SK and F 83959; Social behaviour

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; PHENCYCLIDINE; SKF 83393; SULPIRIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SOCIAL BEHAVIOR; SOCIAL INTERACTION; SOCIAL ISOLATION; STEREOTYPY;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; HALLUCINOGENS; MALE; PHENCYCLIDINE; RATS; RATS, WISTAR; SOCIAL ISOLATION; STEREOTYPED BEHAVIOR;

EID: 0031962877     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050500     Document Type: Article

References (46)

1. 1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Eur J Pharmacol 213:259-267
2. Ban TA, Lohrenz JJ, Lehmann HE (1961) Observations on the action of sernyl a new psychotropic drug. Can Psychiatr Assoc J 6:150-157
3. Bodi T, Share I, Levy H, Moyer JH (1959) Clinical trials of phencyclidine (sernyl) in patients with psychoneurosis. Antibio Med Clin Ther 6:79-84
4. 3 receptor agonist (+)-PD 128907. Neuropharmacology 35: 285-294
5. Carlsson M, Carlsson A (1990) Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophr Bull 16: 425-432
6. Castellani S, Adams PM (1981) Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur J Pharmacol 73:143-154
7. Corbett R, Camacho F, Woods AT, Kerman LL, Fishkin RJ, Brooks K, Dunn RW (1995) Antipsychotic agents antagonize non-competitive N-methyl-d-asparatate antagonist-induced behaviors. Psychopharmacology 120:67-74
8. Criswell HE, Johnson KB, Mueller RA, Breese GR (1993) Evidence for involvement of brain dopamine and other mechanism in the behavioural action of the N-methyl-D-asparatic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats. J Pharmacol Exp Ther 265:1001-1010
9. Dall'Olio R, Gandolfi O, Montanaro N (1992) Effects of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat. Psychopharmacology 107:591-594
10. Davies BM, Beech HR (1960) The effects of 1-arylcyclohexylamine (sernyl) on twelve normal volunteers. J Ment Sci 106: 912-914
11. 1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia. Psychopharmacology 121:317-322
12. Dwoskin LP, Jewell AL, Buxton ST, Carney JM (1992) Phencyclidine-induced desensitization of striatal dopamine release. Neuropharmacology 31:1033-1039
13. 1 receptors drugs that attenuate both positive and negative symptoms of schizophrenia? A pilot study in java monkeys. Neuropsychopharmacology 2:191-199
14. Erard R, Luisada PV, Peele R (1980) The PCP psychosis: prolonged intoxication or drug-precipitated functional illness? J Psyched Drugs 12:235-251
15. Factor SA, Molho ES, Podkalny GD, Brown D (1995) Parkinson's disease: drug-induced psychiatric states. In: Weiner WJ, Lang AE (eds) Behavioural neurology of movement disorders (Advances in Neurology, vol 65). Raven Press, New York, pp 115-138
16. 2 receptors. Eur J Pharmacol 255:203-213
17. File SE (1980) The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods 2:219-238
18. Fitzgerald LW, Deutch AY, Gasic G, Heinemann SF, Nestler E (1995) Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J Neurosci 15:2453-2461
19. Freed WJ (1994) Glutamatergic mechanisms mediating stimulant and antipsychotic drug effects. Neurosci Biobehav Rev 18:111-120
20. Garey RE, McQuitty S, Tootle C, Heath RG (1980) The effects of apomorphine and haldol on PCP induced behavioral and motor abnormalities in the rat. Life Sci 26:277-284
21. Greifenstein FE, Yoshitake J, DeValut M, Gajewski, JE (1958) A study of 1-aryl cyclo hexyl amine for anesthesia. Anesth Analg 37:283-294
22. Healy DJ, Meador-Woodruff JH (1996) Dopamine receptor gene expression in hippocampus is differentially regulated by the NMDA receptor antagonist MK-801. Eur J Pharmacol 306: 257-264
23. Hoffman DC (1992) Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats. J Neural Transm 89:1-10
24. Huitema BE (1980) The analysis of covariants and alternatives. Wiley, New York
25. Jackson DM, Johansson C, Lindgren LM, Bengtson A (1994) Dopamine receptor anatagonists block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmacol Biochem Behav 41:465-471
26. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308
27. Karler R, Calder LD, Thai LH, Bedingfield JB (1994) A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine. Brain Res 658:8-14
28. 1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients. Psychopharmacology 121:309-316
29. 4 receptor. J Med Chem 39:1941-1942
30. Martin P, Svensson A, Carlsson A, Carlsson ML (1994) On the roles of dopamine D-1 vs. D-2 receptors for the hyperactivity response elicited by MK-801. J Neural Transm 95:113-121
31. Mauri MC, Patrizia LM, Teresa C, Altamura CA (1994) L-Sulpiride in young and elderly negative schizophrenics : clinical and pharmacokinetic variables. Prog Neuro-Psychopharmacol Biol Psychiatry 18:355-366
32. Meltzer HY (1991) The mechanism of action of novel antipsychotic drugs. Schizophr Bull 17:263-287
33. Murray TF, Horita A (1979) Phencyclidine-induced stereotyped behavior in rats: dose response effects and antagonism by neuroleptics. Life Sci 24:2217-2226
34. 2 receptor blockade on MK-801-induced hyperlocomotion in rats. Psychopharmacology 111:427-434
35. Rothman RB (1994) PCP site 2: a high affinity MK-801-insensitive phencyclidine binding site. Neurotoxicol Teratol 16:343-353
36. Sams-Dodd F (1995a) Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats. Behav Pharmacol 6:55-65
37. Sams-Dodd F (1995b) Automation of the social interaction test by a video tracking system: behavioural effects of repeated phencyclidine treatment. J Neurosci Meth 59:157-168
38. Sams-Dodd F (1996) Phencyclidine-induced stereotyped behaviour and social isolation in the rat: a possible animal model of schizophrenia. Behav Pharmacol 7:3-23
39. Sams-Dodd F (1997) Effect of novel antipsychotic drugs on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test. Behav Pharmacol 8:196-215
40. Siegel RK (1978) Phencyclidine and ketamine intoxication a study of 4 populations of recreational users. In: Peterson RC, Stillman RC (eds) National Institute of Drug Abuse Research Monograph #21. NIH Press, Washington DC, pp 119-147
41. Steinpreis RE, Sokolowski JD, Papanikolaou A, Salamone JD (1994) The effects of haloperidole and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat. Pharmacol Biochem Behav 47:579-585
42. Sturgeon RD, Fessler RG, Meltzer HY (1979) Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behaviour and ataxia in rats. Eur J Pharmacol 59:169-179
43. Sveinbjornsdottir S, Sander JWAS, Upton D, Thompson PJ, Patsalos PN, Hirt D, Emre M, Lowe D, Duncan JS (1993) The excitatory amino acid antagonist d-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res 16:165-174
44. Tiedtke PI, Bischoff C, Schmidt WJ (1990) MK-801-induced stereotypy and its antagonism by neuroleptic drugs. J Neural Transm 81:173-182
45. Verma A, Moghaddam B (1996) NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci 16:373-379
46. Vollenweider FX, Leenders KL, Scharfetter C, Antonini A, Maguire P, Missimer J, Angst J (1997) Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [F-18]flurodeoxyglucose (FDG). Eur Neuropsychopharmacol 7:9-24